Specialty Pharmacy

Endocrinologists seek to create an observational registry so researchers can study thyroid incidentalomas systematically.

Knowing the details about new HIV diagnoses can help pharmacists better understand the infection.

Atezolizumab (Tecentriq) approved for locally advanced or metastatic urothelial carcinoma.

Pharmacists can have a positive influence on medication adherence and several other factors in type 2 diabetes.

Drug-drug and drug-food interactions are evaluated in 58 oral chemotherapeutics.

Uneven distribution of the signaling protein c-Myc could aid the development of cancer vaccines.

The United States reduced cancer mortality by 26% overall, falling short of the 50% reduction goal set by the American Cancer Society.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Nondiscrimination in Health Programs and Activities final rule addresses discrimination and seeks to improve language barriers.

Most patients with locally advanced non-small cell lung cancer with mediastinal lymph node involvement are generally not considered good candidates for surgery.

Opdivo approved for patients with relapsed or refractory classical Hodgkin lymphoma.

NASP outlines issues with the new proposed rule for Medicare Part B.

Contracts will modify the costs of the cholesterol-lowering drugs Repatha and Praluent based on efficacy in patients.

Imbruvica approved for use in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.

Children found to greatly benefit from gene therapy for Leber congenital amaurosis.

Researchers found a protective effect against cancer in patients with autism spectrum disorder.

Top news of the day from across the health care landscape.

Diabetes drug interactions may decrease medication efficacy, increase toxicity, challenge adherence, and cause adverse events.

Worm infection in the gut microbiome shows promise reducing the bacterial species linked to a higher risk of IBD.

Lenvatinib with everolimus found to improve progression-free survival in RCC patients.

Personal preference influence pharmacist recommendations for a host of conditions.

Biomarker can help determine the most effective treatment for patients with multiple myeloma.

Dendritic cell-based therapy shows promise treating diabetic peripheral neuropathy and ulcerations in the cornea and skin.

Top news of the day from across the health care landscape.

Subcapsular sinus macrophages may influence cancer mortality.

Antiandrogen therapy plus radiotherapy shows promise reducing prostate cancer mortality.

Borderline personality disorder leads to more risky sexual behavior, increasing the risk of HIV and other sexually transmitted diseases.